About 200 reports

Rosacea Global Clinical Trials Review, H1, 2016

100 pages • By Global Data

Rosacea Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, H1, 2016" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers...

2 000 2 500 1 440
Mar 2016

Alopecia Global Clinical Trials Review, H1, 2016

151 pages • By Global Data

Alopecia Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Alopecia Global Clinical Trials Review, H1, 2016" provides an overview of Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on Alopecia. Report includes an overview of trial...

2 000 2 500 1 440
Mar 2016

Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2016

123 pages • By Global Data

Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Urticaria Or Hives clinical trials scenario. This report provides top line data relating to the clinical trials...

2 000 2 500 1 440
Mar 2016

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

190 pages • By Global Data

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating to...

2 000 2 500 1 440
Mar 2016

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016

166 pages • By Global Markets Direct

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016SummaryGlobal Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape. The report provides comprehensive information on the therapeutics under development...

1 600 2 000 1 152
Feb 2016

Delenex Therapeutics AG - Product Pipeline Review - 2016

37 pages • By Global Markets Direct

Delenex Therapeutics AG - Product Pipeline Review - 2016SummaryGlobal Markets Direct’s, ‘Delenex Therapeutics AG - Product Pipeline Review - 2016’, provides an overview of the Delenex Therapeutics AG’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics...

1 200 1 500 864
Feb 2016

Stratatech Corporation - Product Pipeline Analysis, 2016 Update

32 pages • By Global Data

SummaryStratatech Corporation (Stratatech) is a regenerative medicine company offers skin regeneration therapies. The company offers ExpressGraft genetically enhanced skin tissues and StrataGraft skin tissues. Its StrataGraft skin tissues provide mimic natural human skin, with both dermal and fully differentiated epidermal layers...

600 750 432
Feb 2016

Atopic dermatitis: An increased focus on development of targeted therapies will address key unmet needs - Marketed Drugs, Pipeline, Forecast, Treatment and Epidemiology

191 pages • By Datamonitor Healthcare

Datamonitor Healthcare’s comprehensive atopic dermatitis report provides a 10-year patient based sales forecast, key prescribing information based on a survey of 216 dermatologists, marketed and pipeline profiles, and a 20-year epidemiology forecast. The reports covers key marketed therapies for atopic dermatitis, as well as analysis and forecasts...

16 000 20 000 12 800
Jan 2016

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015

313 pages • By Global Data

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Aesthetic Devices currently in pipeline stage.The report provides comprehensive information on the pipeline products...

3 200 4 000 2 304
Jan 2016

Skin Disease Treatment Technologies and Global Markets

128 pages • By BCC Research

This BCC Research report provides detailed market, technology and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of the major skin diseases. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2020. Use this...

5 320 6 650 4 256
Jan 2016

Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Angioedema Report is to understand the market and pipeline...

1 600 2 000 1 280
Jan 2016

Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Cellulitis Report is to understand the market and pipeline...

1 600 2 000 1 280
Jan 2016

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Acne Vulgaris Report is to understand the market...

1 600 2 000 1 280
Jan 2016

Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Genital Warts (Condylomata...

1 600 2 000 1 280
Jan 2016

Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Dermatitis Report is to understand the market and pipeline...

1 600 2 000 1 280
Jan 2016

Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Lichen Simplex Chronicus...

1 600 2 000 1 280
Jan 2016

Actinic Keratosis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Actinic Keratosis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Actinic Keratosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 000 1 250 800
Jan 2016

Systemic Sclerosis (Scleroderma)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Systemic Sclerosis (Scleroderma)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Systemic Sclerosis (Scleroderma). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 000 1 250 800
Jan 2016

Xerosis (Dry Skin)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Xerosis (Dry Skin)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Xerosis (Dry Skin). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 000 1 250 800
Jan 2016

Hirsutism-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Hirsutism-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hirsutism. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Cutaneous Lupus Erythematosus-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Cutaneous Lupus Erythematosus-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous Lupus Erythematosus. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND,...

1 000 1 250 800
Jan 2016

Pruritus-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Pruritus-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Pruritus. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Urticaria Or Hives Report is...

1 600 2 000 1 280
Jan 2016

Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hereditary Angioedema (HAE) Report...

1 600 2 000 1 280
Jan 2016

Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Onychomycosis (Tinea Unguium) Report...

1 600 2 000 1 280
Jan 2016

Epidermolysis Bullosa-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Epidermolysis Bullosa-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Epidermolysis Bullosa. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 000 1 250 800
Jan 2016

Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Genital Warts (Condylomata Acuminata). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 000 1 250 800
Jan 2016

Subacute Cutaneous Lupus Erythematosus (SCLE)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Subacute Cutaneous Lupus Erythematosus (SCLE)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Subacute Cutaneous Lupus Erythematosus (SCLE). The DelveInsight’sReport covers the product profiles in various stages of development including...

1 000 1 250 800
Jan 2016

Systemic Mastocytosis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Systemic Mastocytosis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Systemic Mastocytosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 000 1 250 800
Jan 2016

Angioedema-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Angioedema-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Angioedema. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016